Showing 1 - 10 of 1,070
This paper examines the effect of foreign direct investment (FDI) on domestic innovation based on a data set covering the pharmaceutical industries across 29 provinces in the People's Republic of China (PRC) over the period 1998-2007. We show that there is a negative horizontal spillover effect...
Persistent link: https://www.econbiz.de/10011723712
We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...
Persistent link: https://www.econbiz.de/10014287391
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external knowledge, which helps improve their internal drug development...
Persistent link: https://www.econbiz.de/10012832198
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external knowledge, which helps improve their internal drug...
Persistent link: https://www.econbiz.de/10012219514
Persistent link: https://www.econbiz.de/10012286857
Persistent link: https://www.econbiz.de/10012207272
Persistent link: https://www.econbiz.de/10002113981
Persistent link: https://www.econbiz.de/10003484669
Persistent link: https://www.econbiz.de/10003948499
Persistent link: https://www.econbiz.de/10003957629